Hound Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.2M | Buy |
97,724
+54,456
| +126% | +$15.7M | 3.44% | 9 |
|
|
2025
Q4 | $13.1M | Sell |
43,268
-60,695
| -58% | -$18.9M | 1.82% | 14 |
|
|
2025
Q3 | $29.2M | Sell |
103,963
-77,973
| -43% | -$21.2M | 3.74% | 7 |
|
|
2025
Q2 | $43.9M | Sell |
181,936
-19,847
| -10% | -$4.69M | 5.93% | 7 |
|
|
2025
Q1 | $49.1M | Buy |
201,783
+142,925
| +243% | +$43M | 9.75% | 5 |
|
|
2024
Q4 | $19.3M | Sell |
58,858
-9,502
| -14% | -$3.23M | 9.29% | 4 |
|
|
2024
Q3 | $22.9M | Sell |
68,360
-96,510
| -59% | -$30.7M | 5.72% | 6 |
|
|
2024
Q2 | $45M | Sell |
164,870
-99,667
| -38% | -$29M | 9.03% | 4 |
|
|
2024
Q1 | $91.5M | Buy |
264,537
+2,873
| +1% | +$945K | 27.27% | 1 |
|
|
2023
Q4 | $84.5M | Buy |
261,664
+47,682
| +22% | +$14.9M | 26.33% | 1 |
|
|
2023
Q3 | $76.7M | Sell |
213,982
-2,564
| -1% | -$989K | 17% | 2 |
|
|
2023
Q2 | $82.1M | Buy |
216,546
+96,970
| +81% | +$39.5M | 18.63% | 1 |
|
|
2023
Q1 | $57.3M | Buy |
119,576
+31,222
| +35% | +$14.6M | 14.42% | 1 |
|
|
2022
Q4 | $37.2M | Buy |
88,354
+34,947
| +65% | +$14.1M | 10.99% | 5 |
|
|
2022
Q3 | $22.3M | Sell |
53,407
-10,014
| -16% | -$4.99M | 4.23% | 8 |
|
|
2022
Q2 | $31.4M | Buy |
+63,421
| New | +$33M | 2.55% | 12 |
|
|
2021
Q3 | – | Sell |
-72,264
| Closed | -$46.6M | – | 212 |
|
|
2021
Q2 | $46.6M | Sell |
72,264
-5,593
| -7% | -$3.4M | 2.33% | 17 |
|
|
2021
Q1 | $44.5M | Buy |
77,857
+4,285
| +6% | +$2.54M | 2.18% | 18 |
|
|
2020
Q4 | $42.9M | Sell |
73,572
-13,522
| -16% | -$7.7M | 2.72% | 17 |
|
|
2020
Q3 | $44.9M | Sell |
87,094
-558
| -0.6% | -$283K | 3.08% | 15 |
|
|
2020
Q2 | $39.6M | Sell |
87,652
-22,300
| -20% | -$9.84M | 3.64% | 13 |
|
|
2020
Q1 | $38.5M | Buy |
+109,952
| New | +$40.4M | 3.63% | 12 |
|
Other funds holding BIO
VCM
VPM
AI
